Charles C. Wykoff

Charles C. Wykoff, MD, PhD is Director of Research at Retina Consultants of Texas and Chairman of Research, Retina Consultants of America.  He is passionate about translational research and accelerating drug and device development.

He has published over 350 peer-reviewed manuscripts and serves on multiple scientific and medical advisory boards, safety monitoring committees, and global steering committees for endeavors spanning the innovative process from early to late-stage developments. He serves on the ASRS Executive Committee and Board of Directors, is a founding member of the Ophthalmology Retina Editorial Board, and is a past President of the Vit-Buckle Society for which he is an Emeritus member of the Board of Trustees.

He received his baccalaureate from MIT, PhD from Oxford University while on a Marshall Scholarship, and MD from Harvard Medical School. His basic science research related to cellular adaptation to oxygen availability and HIF biology contributed to the 2019 Nobel Prize in Medicine that was awarded to his PhD supervisor Peter Ratcliffe. He completed retina fellowship at Bascom Palmer Eye Institute where he served as Chief Resident/Co-Director of Ocular Trauma and received a Heed Fellowship and the Ronald G. Michels Award.

He is a member of the NEI Audacious Goals Steering Committee and has been awarded multiple Achievement, Honor and Senior Honor Awards. His guiding philosophy is to build and strengthen innovative, ethical teams focused on developing new approaches to improving outcomes for blinding diseases.